|
GIGYF2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.69435601502255E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.13549999964025E-07 |
| Normal-vs-Stage2 |
7.72900000001187E-07 |
| Normal-vs-Stage3 |
3.23963078585621E-12 |
| Normal-vs-Stage4 |
2.105871033109E-12 |
| Stage1-vs-Stage2 |
1.369000E-01 |
| Stage1-vs-Stage3 |
1.807030E-04 |
| Stage1-vs-Stage4 |
8.36620000000954E-05 |
| Stage2-vs-Stage3 |
2.265200E-01 |
| Stage2-vs-Stage4 |
9.653800E-02 |
| Stage3-vs-Stage4 |
6.075600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.90436596784139E-12 |
| Normal-vs-AfricanAmerican |
8.21370000014809E-07 |
| Normal-vs-Asian |
3.672000E-01 |
| Caucasian-vs-AfricanAmerican |
9.410000E-01 |
| Caucasian-vs-Asian |
1.329790E-01 |
| AfricanAmerican-vs-Asian |
1.608970E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.66533453693773E-15 |
| Normal-vs-Female |
2.12939999999495E-05 |
| Male-vs-Female |
5.53449999999289E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.70969999999404E-06 |
| Normal-vs-Age(41-60Yrs) |
3.36359995412039E-09 |
| Normal-vs-Age(61-80Yrs) |
2.87110335506213E-11 |
| Normal-vs-Age(81-100Yrs) |
5.72279999999648E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.365200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.768400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.616400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.723600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.982400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.492200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.364200E-01 |
| Normal-vs-Grade 2 |
4.82199999929378E-08 |
| Normal-vs-Grade 3 |
3.6078029452824E-11 |
| Normal-vs-Grade 4 |
1.65367719517917E-12 |
| Grade 1-vs-Grade 2 |
4.436300E-02 |
| Grade 1-vs-Grade 3 |
7.335100E-03 |
| Grade 1-vs-Grade 4 |
6.23250000000297E-05 |
| Grade 2-vs-Grade 3 |
4.152000E-02 |
| Grade 2-vs-Grade 4 |
2.1552999999952E-05 |
| Grade 3-vs-Grade 4 |
6.864600E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.609800E-04 |
| Normal-vs-ccB subtype |
1.6251444634463E-12 |
| ccA subtype-vs-ccB subtype |
9.50699963198076E-10 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.47419989946241E-10 |
| Normal-vs-N1 |
1.606910E-04 |
| N0-vs-N1 |
3.744600E-01 |
|
|
